INVESTOR RELATION BACK NUMBER

SEARCH
2018.02.14
Announcement of Financial Results for the Nine Months Ended December 31, 2017
2017.12.05
With regards to the reports on CYBERDYNE’s investee in the past
2017.11.14
Announcement of Financial Results for the Six-Months Ended September 30, 2017
2017.10.18
Notice of changed contract on consigned research by the JST and anticipation of posting in non-operative income
2017.10.10
AMED adopts CYBERDYNE’s research proposal on HAL Single Joint Type for “Project to Accelerate Medical Device Development”
2017.10.02
Notice on posting of a gain on sale of investment securities (extraordinary income)
2017.09.07
Analyst Interview : “CYBERDYNE’s Challenges to Shape the Future”
2017.08.15
Notice on investigator-initiated multicenter parallel-group clinical trial on HAL—HN-01 for rare-intractable spinal cord diseases to expand target diseases
2017.08.14
Announcement of Financial Results for the Three Months Ended June 30, 2017
2017.08.09
Notice regarding confirmation of issuance of the stock option (stock acquisition rights)
2017.07.25
Notice Regarding the Issuance of Stock Options (Stock Acquisition Rights)
2017.06.19
Ibaraki prefecture adopts CYBERDYNE’s project for its subsidized project in 2017
2017.05.22
Notice regarding issuance of stock options (stock acquisition rights)
2017.05.15
Announcement of Financial Results for the Year Ending March 31, 2017
2017.02.14
Financial Results Briefing for the Nine Months Ended December 31, 2016
2017.01.12
Anticipated posting of non-operating income
2016.12.14
CYBERDYNE, INC.’s view on the research report released by Citron Research (Part 4)
2016.11.14
Financial Results Briefing for the Six Months Ended September 30, 2016
2016.11.14
Announcement of Financial Results for the Six Months Ended September 30,2016
2016.10.28
Fukushima prefecture accepted CYBERDYNE, INC.’s application to increase the subsidy amount for its plan eligible for “Fukushima Medical and Welfare Device Development Subsidy”
BACK TO TOP